Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair

Yi Dong Lin, Chwan Yau Luo, Yu Ning Hu, Ming Long Yeh, Ying Chang Hsueh, Min Yao Chang, Da Ching Tsai, Jieh Neng Wang, Ming Jer Tang, Erika I.H. Wei, Matthew L. Springer, Patrick C.H. Hsieh

研究成果: Article

102 引文 (Scopus)

摘要

Angiogenic therapy is a promising approach for tissue repair and regeneration. However, recent clinical trials with protein delivery or gene therapy to promote angiogenesis have failed to provide therapeutic effects. A key factor for achieving effective revascularization is the durability of the microvasculature and the formation of new arterial vessels. Accordingly, we carried out experiments to test whether intramyocardial injection of self-assembling peptide nanofibers (NFs) combined with vascular endothelial growth factor (VEGF) could create an intramyocardial microenvironment with prolonged VEGF release to improve post-infarct neovascularization in rats. Our data showed that when injected with NF, VEGF delivery was sustained within the myocardium for up to 14 days, and the side effects of systemic edema and proteinuria were significantly reduced to the same level as that of control. NF/VEGF injection significantly improved angiogenesis, arteriogenesis, and cardiac performance 28 days after myocardial infarction. NF/VEGF injection not only allowed controlled local delivery but also transformed the injected site into a favorable microenvironment that recruited endogenous myofibroblasts and helped achieve effective revascularization. The engineered vascular niche further attracted a new population of cardiomyocyte-like cells to home to the injected sites, suggesting cardiomyocyte regeneration. Follow-up studies in pigs also revealed healing benefits consistent with observations in rats. In summary, this study demonstrates a new strategy for cardiovascular repair with potential for future clinical translation.

原文English
文章編號146ra109
期刊Science Translational Medicine
4
發行號146
DOIs
出版狀態Published - 2012 八月 8

指紋

Nanofibers
Vascular Endothelial Growth Factor A
Cardiac Myocytes
Injections
Regeneration
Myofibroblasts
Therapeutic Uses
Microvessels
Proteinuria
Genetic Therapy
Blood Vessels
Edema
Myocardium
Swine
Myocardial Infarction
Clinical Trials
Peptides
Population
Proteins

All Science Journal Classification (ASJC) codes

  • Medicine(all)

引用此文

Lin, Yi Dong ; Luo, Chwan Yau ; Hu, Yu Ning ; Yeh, Ming Long ; Hsueh, Ying Chang ; Chang, Min Yao ; Tsai, Da Ching ; Wang, Jieh Neng ; Tang, Ming Jer ; Wei, Erika I.H. ; Springer, Matthew L. ; Hsieh, Patrick C.H. / Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair. 於: Science Translational Medicine. 2012 ; 卷 4, 編號 146.
@article{619e176ed33b4dba8ce9a9d3489c2a4d,
title = "Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair",
abstract = "Angiogenic therapy is a promising approach for tissue repair and regeneration. However, recent clinical trials with protein delivery or gene therapy to promote angiogenesis have failed to provide therapeutic effects. A key factor for achieving effective revascularization is the durability of the microvasculature and the formation of new arterial vessels. Accordingly, we carried out experiments to test whether intramyocardial injection of self-assembling peptide nanofibers (NFs) combined with vascular endothelial growth factor (VEGF) could create an intramyocardial microenvironment with prolonged VEGF release to improve post-infarct neovascularization in rats. Our data showed that when injected with NF, VEGF delivery was sustained within the myocardium for up to 14 days, and the side effects of systemic edema and proteinuria were significantly reduced to the same level as that of control. NF/VEGF injection significantly improved angiogenesis, arteriogenesis, and cardiac performance 28 days after myocardial infarction. NF/VEGF injection not only allowed controlled local delivery but also transformed the injected site into a favorable microenvironment that recruited endogenous myofibroblasts and helped achieve effective revascularization. The engineered vascular niche further attracted a new population of cardiomyocyte-like cells to home to the injected sites, suggesting cardiomyocyte regeneration. Follow-up studies in pigs also revealed healing benefits consistent with observations in rats. In summary, this study demonstrates a new strategy for cardiovascular repair with potential for future clinical translation.",
author = "Lin, {Yi Dong} and Luo, {Chwan Yau} and Hu, {Yu Ning} and Yeh, {Ming Long} and Hsueh, {Ying Chang} and Chang, {Min Yao} and Tsai, {Da Ching} and Wang, {Jieh Neng} and Tang, {Ming Jer} and Wei, {Erika I.H.} and Springer, {Matthew L.} and Hsieh, {Patrick C.H.}",
year = "2012",
month = "8",
day = "8",
doi = "10.1126/scitranslmed.3003841",
language = "English",
volume = "4",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "146",

}

Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair. / Lin, Yi Dong; Luo, Chwan Yau; Hu, Yu Ning; Yeh, Ming Long; Hsueh, Ying Chang; Chang, Min Yao; Tsai, Da Ching; Wang, Jieh Neng; Tang, Ming Jer; Wei, Erika I.H.; Springer, Matthew L.; Hsieh, Patrick C.H.

於: Science Translational Medicine, 卷 4, 編號 146, 146ra109, 08.08.2012.

研究成果: Article

TY - JOUR

T1 - Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair

AU - Lin, Yi Dong

AU - Luo, Chwan Yau

AU - Hu, Yu Ning

AU - Yeh, Ming Long

AU - Hsueh, Ying Chang

AU - Chang, Min Yao

AU - Tsai, Da Ching

AU - Wang, Jieh Neng

AU - Tang, Ming Jer

AU - Wei, Erika I.H.

AU - Springer, Matthew L.

AU - Hsieh, Patrick C.H.

PY - 2012/8/8

Y1 - 2012/8/8

N2 - Angiogenic therapy is a promising approach for tissue repair and regeneration. However, recent clinical trials with protein delivery or gene therapy to promote angiogenesis have failed to provide therapeutic effects. A key factor for achieving effective revascularization is the durability of the microvasculature and the formation of new arterial vessels. Accordingly, we carried out experiments to test whether intramyocardial injection of self-assembling peptide nanofibers (NFs) combined with vascular endothelial growth factor (VEGF) could create an intramyocardial microenvironment with prolonged VEGF release to improve post-infarct neovascularization in rats. Our data showed that when injected with NF, VEGF delivery was sustained within the myocardium for up to 14 days, and the side effects of systemic edema and proteinuria were significantly reduced to the same level as that of control. NF/VEGF injection significantly improved angiogenesis, arteriogenesis, and cardiac performance 28 days after myocardial infarction. NF/VEGF injection not only allowed controlled local delivery but also transformed the injected site into a favorable microenvironment that recruited endogenous myofibroblasts and helped achieve effective revascularization. The engineered vascular niche further attracted a new population of cardiomyocyte-like cells to home to the injected sites, suggesting cardiomyocyte regeneration. Follow-up studies in pigs also revealed healing benefits consistent with observations in rats. In summary, this study demonstrates a new strategy for cardiovascular repair with potential for future clinical translation.

AB - Angiogenic therapy is a promising approach for tissue repair and regeneration. However, recent clinical trials with protein delivery or gene therapy to promote angiogenesis have failed to provide therapeutic effects. A key factor for achieving effective revascularization is the durability of the microvasculature and the formation of new arterial vessels. Accordingly, we carried out experiments to test whether intramyocardial injection of self-assembling peptide nanofibers (NFs) combined with vascular endothelial growth factor (VEGF) could create an intramyocardial microenvironment with prolonged VEGF release to improve post-infarct neovascularization in rats. Our data showed that when injected with NF, VEGF delivery was sustained within the myocardium for up to 14 days, and the side effects of systemic edema and proteinuria were significantly reduced to the same level as that of control. NF/VEGF injection significantly improved angiogenesis, arteriogenesis, and cardiac performance 28 days after myocardial infarction. NF/VEGF injection not only allowed controlled local delivery but also transformed the injected site into a favorable microenvironment that recruited endogenous myofibroblasts and helped achieve effective revascularization. The engineered vascular niche further attracted a new population of cardiomyocyte-like cells to home to the injected sites, suggesting cardiomyocyte regeneration. Follow-up studies in pigs also revealed healing benefits consistent with observations in rats. In summary, this study demonstrates a new strategy for cardiovascular repair with potential for future clinical translation.

UR - http://www.scopus.com/inward/record.url?scp=84864866891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864866891&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.3003841

DO - 10.1126/scitranslmed.3003841

M3 - Article

C2 - 22875829

AN - SCOPUS:84864866891

VL - 4

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 146

M1 - 146ra109

ER -